NasdaqGM - Delayed Quote USD

Alvotech (ALVO)

Compare
13.02 +0.04 (+0.31%)
At close: November 1 at 4:00 PM EDT

Environment, Social and Governance (ESG) Risk Ratings

Total ESG Risk Score

29.5

Medium

ESG Risk Score for Peers

NameTotal ESG Risk scoreESG
CARA Cara Therapeutics, Inc. 29 -- -- --
ZYME Zymeworks Inc. 29 -- -- --
ALVO Alvotech 29 -- -- --
VRDN Viridian Therapeutics, Inc. 29 -- -- --
TGTX TG Therapeutics, Inc. 29 -- -- --

Controversy Level

ESG data provided by Sustainalytics, Inc. Last Updated on 10/2024
ALVO
Category Average
1 Low Controversy Level
None 4 Severe

Product Involvement Areas

Products and Activities Significant Involvement
Alcoholic Beverages No
Adult Entertainment No
Gambling No
Tobacco Products No
Animal Testing Yes
Fur and Specialty Leather No
Controversial Weapons No
Small Arms No
Catholic Values No
GMO No
Military Contracting No
Pesticides No
Thermal Coal No
Palm Oil No

Related Tickers